Clinical Trial Update: Body Fat Reducing Effect and Safety of Enzymatically Modified Isoquercitrin in Overweight and Obese Subjects [NA]

View source ↗

Summary

A completed clinical trial evaluated the body fat reducing effects and safety of enzymatically modified isoquercitrin (EMIQ) in overweight and obese adults. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Enzymatically Modified Isoquercitrin (enzymatically modified isoquercitrin)

Snippet

Sponsor: Tufts University | Conditions: Overweight, Obese | NA | Status: COMPLETED